[{"id":"3a3c09ba-f512-4df6-b272-3d719b2056f2","acronym":"","url":"https://clinicaltrials.gov/study/NCT04036019","created_at":"2021-01-18T19:48:18.141Z","updated_at":"2024-07-02T16:35:00.627Z","phase":"Phase 1","brief_title":"A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy","source_id_and_acronym":"NCT04036019","lead_sponsor":"Shanghai Tongji Hospital, Tongji University School of Medicine","biomarkers":" CD20","pipe":"","alterations":" ","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JNJ-9530"],"overall_status":"Completed","enrollment":" Enrollment 13","initiation":"Initiation: 08/20/2019","start_date":" 08/20/2019","primary_txt":" Primary completion: 06/20/2022","primary_completion_date":" 06/20/2022","study_txt":" Completion: 06/20/2022","study_completion_date":" 06/20/2022","last_update_posted":"2024-05-28"},{"id":"2b258e91-81d7-4ee9-a691-2b0389d0815d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04316624","created_at":"2021-01-18T20:55:15.288Z","updated_at":"2024-07-02T16:35:42.642Z","phase":"Phase 1","brief_title":"A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy","source_id_and_acronym":"NCT04316624","lead_sponsor":"Institute of Hematology \u0026 Blood Diseases Hospital","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JNJ-9530"],"overall_status":"Completed","enrollment":" Enrollment 7","initiation":"Initiation: 09/29/2019","start_date":" 09/29/2019","primary_txt":" Primary completion: 02/08/2023","primary_completion_date":" 02/08/2023","study_txt":" Completion: 02/08/2023","study_completion_date":" 02/08/2023","last_update_posted":"2023-07-19"}]